Dr. Reddy's Laboratories Limited (DRREDDY.NS)
INR 1154.9
(4.09%)
INR 1154.9
(4.09%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 279.16 Billion INR | 13.54% |
| 2022 | 245.87 Billion INR | 14.69% |
| 2021 | 214.39 Billion INR | 13.0% |
| 2020 | 189.72 Billion INR | 8.66% |
| 2019 | 174.6 Billion INR | 13.49% |
| 2018 | 153.85 Billion INR | 8.32% |
| 2017 | 142.02 Billion INR | 0.87% |
| 2016 | 140.8 Billion INR | -8.98% |
| 2015 | 154.7 Billion INR | 4.4% |
| 2014 | 148.18 Billion INR | 12.12% |
| 2013 | 132.17 Billion INR | 13.68% |
| 2012 | 116.26 Billion INR | 20.19% |
| 2011 | 96.73 Billion INR | 29.51% |
| 2010 | 74.69 Billion INR | 6.28% |
| 2009 | 70.27 Billion INR | 1.2% |
| 2008 | 69.44 Billion INR | 38.87% |
| 2007 | 50 Billion INR | -23.36% |
| 2006 | 65.24 Billion INR | 168.19% |
| 2005 | 24.32 Billion INR | 24.95% |
| 2004 | 19.47 Billion INR | -3.24% |
| 2003 | 20.12 Billion INR | 11.69% |
| 2002 | 18.01 Billion INR | 8.51% |
| 2001 | 16.6 Billion INR | 51.85% |
| 2000 | 10.93 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 76.72 Billion INR | 8.33% |
| 2024 Q2 | 80.16 Billion INR | 4.48% |
| 2023 Q4 | 70.83 Billion INR | -1.83% |
| 2023 Q2 | 68.8 Billion INR | 2.1% |
| 2023 Q1 | 67.38 Billion INR | 7.01% |
| 2023 Q3 | 72.14 Billion INR | 4.86% |
| 2023 FY | 279.16 Billion INR | 13.54% |
| 2022 Q1 | 52.15 Billion INR | -4.07% |
| 2022 FY | 245.87 Billion INR | 14.69% |
| 2022 Q4 | 62.96 Billion INR | -6.99% |
| 2022 Q3 | 67.7 Billion INR | 7.36% |
| 2022 Q2 | 63.05 Billion INR | 20.91% |
| 2021 Q1 | 49.19 Billion INR | 4.04% |
| 2021 Q2 | 57.63 Billion INR | 17.15% |
| 2021 FY | 214.39 Billion INR | 13.0% |
| 2021 Q3 | 53.19 Billion INR | -7.7% |
| 2021 Q4 | 54.36 Billion INR | 2.2% |
| 2020 Q2 | 48.96 Billion INR | 10.85% |
| 2020 Q4 | 47.28 Billion INR | -4.08% |
| 2020 FY | 189.72 Billion INR | 8.66% |
| 2020 Q3 | 49.29 Billion INR | 0.67% |
| 2020 Q1 | 44.17 Billion INR | -0.32% |
| 2019 Q4 | 44.31 Billion INR | 1.09% |
| 2019 FY | 174.6 Billion INR | 13.49% |
| 2019 Q3 | 43.83 Billion INR | -8.69% |
| 2019 Q1 | 38.43 Billion INR | -4.31% |
| 2019 Q2 | 48 Billion INR | 24.91% |
| 2018 Q4 | 40.16 Billion INR | 4.33% |
| 2018 FY | 153.85 Billion INR | 8.32% |
| 2018 Q1 | 37.2 Billion INR | 5.26% |
| 2018 Q2 | 37.97 Billion INR | 2.07% |
| 2018 Q3 | 38.5 Billion INR | 1.37% |
| 2017 FY | 142.02 Billion INR | 0.87% |
| 2017 Q4 | 35.34 Billion INR | -7.12% |
| 2017 Q3 | 38.06 Billion INR | 7.33% |
| 2017 Q2 | 35.46 Billion INR | 6.94% |
| 2017 Q1 | 33.15 Billion INR | -6.7% |
| 2016 Q3 | 37.06 Billion INR | 3.37% |
| 2016 Q2 | 35.85 Billion INR | 10.86% |
| 2016 FY | 140.8 Billion INR | -8.98% |
| 2016 Q1 | 32.34 Billion INR | -13.89% |
| 2016 Q4 | 35.54 Billion INR | -4.11% |
| 2015 Q3 | 39.67 Billion INR | -0.53% |
| 2015 Q4 | 37.56 Billion INR | -5.34% |
| 2015 Q1 | 37.57 Billion INR | -2.91% |
| 2015 Q2 | 39.88 Billion INR | 6.15% |
| 2015 FY | 154.7 Billion INR | 4.4% |
| 2014 Q1 | 35.17 Billion INR | 1.05% |
| 2014 FY | 148.18 Billion INR | 12.12% |
| 2014 Q4 | 38.7 Billion INR | 0.71% |
| 2014 Q3 | 38.43 Billion INR | 7.11% |
| 2014 Q2 | 35.87 Billion INR | 2.0% |
| 2013 FY | 132.17 Billion INR | 13.68% |
| 2013 Q3 | 35.33 Billion INR | 5.25% |
| 2013 Q2 | 33.57 Billion INR | 18.02% |
| 2013 Q1 | 28.44 Billion INR | -14.82% |
| 2013 Q4 | 34.8 Billion INR | -1.5% |
| 2012 Q1 | 25.4 Billion INR | -4.43% |
| 2012 Q2 | 28.8 Billion INR | 13.39% |
| 2012 Q3 | 28.65 Billion INR | -0.55% |
| 2012 Q4 | 33.4 Billion INR | 16.58% |
| 2012 FY | 116.26 Billion INR | 20.19% |
| 2011 Q1 | 19.78 Billion INR | -1.93% |
| 2011 FY | 96.73 Billion INR | 29.51% |
| 2011 Q2 | 22.67 Billion INR | 14.63% |
| 2011 Q3 | 27.69 Billion INR | 22.11% |
| 2011 Q4 | 26.58 Billion INR | -4.0% |
| 2010 FY | 74.69 Billion INR | 6.28% |
| 2010 Q4 | 20.17 Billion INR | 6.26% |
| 2010 Q3 | 18.98 Billion INR | 1.5% |
| 2010 Q2 | 18.7 Billion INR | 11.13% |
| 2010 Q1 | 16.83 Billion INR | 2.48% |
| 2009 Q1 | 18.18 Billion INR | -8.37% |
| 2009 FY | 70.27 Billion INR | 1.2% |
| 2009 Q4 | 16.42 Billion INR | -5.05% |
| 2009 Q3 | 17.29 Billion INR | -5.84% |
| 2009 Q2 | 18.36 Billion INR | 0.98% |
| 2008 Q3 | 18.4 Billion INR | 13.93% |
| 2008 Q4 | 19.85 Billion INR | 7.88% |
| 2008 Q2 | 16.15 Billion INR | 7.4% |
| 2008 Q1 | 15.03 Billion INR | 13.77% |
| 2008 FY | 69.44 Billion INR | 38.87% |
| 2007 Q1 | 12 Billion INR | -23.03% |
| 2007 Q4 | 13.21 Billion INR | 7.2% |
| 2007 Q3 | 12.33 Billion INR | 1.12% |
| 2007 Q2 | 12.19 Billion INR | 1.57% |
| 2007 FY | 50 Billion INR | -23.36% |
| 2006 Q2 | 19.97 Billion INR | 41.9% |
| 2006 Q1 | 14.07 Billion INR | 101.01% |
| 2006 FY | 65.24 Billion INR | 168.19% |
| 2006 Q4 | 15.59 Billion INR | 0.8% |
| 2006 Q3 | 15.47 Billion INR | -22.51% |
| 2005 Q2 | 5.74 Billion INR | 2.84% |
| 2005 Q1 | 5.58 Billion INR | 2.65% |
| 2005 Q4 | 7 Billion INR | 18.19% |
| 2005 Q3 | 5.92 Billion INR | 3.1% |
| 2005 FY | 24.32 Billion INR | 24.95% |
| 2004 Q3 | 4.33 Billion INR | -19.81% |
| 2004 Q4 | 5.44 Billion INR | 25.52% |
| 2004 Q2 | 5.4 Billion INR | 5.89% |
| 2004 Q1 | 5.1 Billion INR | 6.42% |
| 2004 FY | 19.47 Billion INR | -3.24% |
| 2003 Q4 | 4.79 Billion INR | -6.61% |
| 2003 FY | 20.12 Billion INR | 11.69% |
| 2003 Q1 | 4.83 Billion INR | 14.53% |
| 2003 Q2 | 5.38 Billion INR | 11.48% |
| 2003 Q3 | 5.13 Billion INR | -4.66% |
| 2002 Q2 | 4.92 Billion INR | 8.67% |
| 2002 FY | 18.01 Billion INR | 8.51% |
| 2002 Q4 | 4.22 Billion INR | -3.15% |
| 2002 Q3 | 4.35 Billion INR | -11.55% |
| 2002 Q1 | 4.53 Billion INR | 15.04% |
| 2001 Q1 | 2.99 Billion INR | 0.0% |
| 2001 FY | 16.6 Billion INR | 51.85% |
| 2001 Q4 | 3.94 Billion INR | -13.64% |
| 2001 Q3 | 4.56 Billion INR | -10.66% |
| 2001 Q2 | 5.1 Billion INR | 70.49% |
| 2000 FY | 10.93 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Hester Biosciences Limited | 3.04 Billion INR | -9066.563% |
| RPG Life Sciences Limited | 5.82 Billion INR | -4696.22% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -2555.281% |
| Ipca Laboratories Limited | 77.05 Billion INR | -262.274% |
| Aarti Drugs Limited | 25.28 Billion INR | -1004.036% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -1437.666% |
| Albert David Limited | 3.62 Billion INR | -7601.89% |
| Alembic Limited | 1.57 Billion INR | -17626.353% |
| Alkem Laboratories Limited | 126.67 Billion INR | -120.377% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | -356.739% |
| Bafna Pharmaceuticals Limited | 1.52 Billion INR | -18209.954% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -5796.777% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -69629.464% |
| Brooks Laboratories Limited | 794.86 Million INR | -35021.109% |
| Eris Lifesciences Limited | 20.09 Billion INR | -1289.468% |
| FDC Limited | 19.42 Billion INR | -1336.81% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -1122.68% |
| Gufic Biosciences Limited | 8.06 Billion INR | -3360.715% |
| Hikal Limited | 17.84 Billion INR | -1464.295% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -2079.437% |
| Ind-Swift Limited | 5.02 Billion INR | -5455.855% |
| Innova Captab Limited | 10.81 Billion INR | -2481.732% |
| IOL Chemicals and Pharmaceuticals Limited | 21.32 Billion INR | -1208.915% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -13276.201% |
| Jubilant Pharmova Limited | 67.02 Billion INR | -316.482% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -17983.791% |
| Laurus Labs Limited | 50.01 Billion INR | -458.127% |
| Lincoln Pharmaceuticals Limited | 5.8 Billion INR | -4708.616% |
| Lupin Limited | 196.56 Billion INR | -42.022% |
| Mangalam Drugs & Organics Limited | 3.67 Billion INR | -7499.327% |
| Medico Remedies Limited | 1.44 Billion INR | -19163.225% |
| Morepen Laboratories Limited | 17.01 Billion INR | -1540.309% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -1557.182% |
| Orchid Pharma Limited | 8.19 Billion INR | -3307.064% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -2324.856% |
| Sigachi Industries Limited | 3.98 Billion INR | -6897.361% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -2154.249% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 42.437% |
| Themis Medicare Limited | 3.81 Billion INR | -7212.537% |
| Unichem Laboratories Limited | 16.57 Billion INR | -1584.333% |
| Vaishali Pharma Limited | 862.79 Million INR | -32255.699% |
| Venus Remedies Limited | 5.91 Billion INR | -4619.996% |
| Wanbury Limited | 5.75 Billion INR | -4749.546% |
| Windlas Biotech Limited | 6.3 Billion INR | -4324.461% |
| ZIM Laboratories Limited | 3.67 Billion INR | -7495.948% |
| Sakar Healthcare Limited | 1.54 Billion INR | -18007.861% |
| Aurobindo Pharma Limited | 290.01 Billion INR | 3.743% |
| Divi's Laboratories Limited | 78.45 Billion INR | -255.85% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -2054.825% |
| Mankind Pharma Limited | 103.34 Billion INR | -170.121% |
| Sequent Scientific Limited | 13.69 Billion INR | -1938.094% |
| Neuland Laboratories Limited | 15.58 Billion INR | -1691.143% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.47 Billion INR | -709.718% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | -136.317% |
| Zydus Lifesciences Limited | 190.21 Billion INR | -46.762% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -6527.345% |
| Wockhardt Limited | 27.89 Billion INR | -900.947% |
| Bal Pharma Limited | 3.39 Billion INR | -8129.595% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -3524.354% |
| Par Drugs and Chemicals Limited | 956.4 Million INR | -29088.92% |
| Caplin Point Laboratories Limited | 16.76 Billion INR | -1564.881% |
| Shilpa Medicare Limited | 11.53 Billion INR | -2320.973% |
| Valiant Laboratories Limited | 1.82 Billion INR | -15233.862% |
| Ajanta Pharma Limited | 42.08 Billion INR | -563.301% |
| Aarey Drugs & Pharmaceuticals Limited | 3.95 Billion INR | -6956.405% |
| Granules India Limited | 45.06 Billion INR | -519.488% |
| Medicamen Biotech Limited | 1.79 Billion INR | -15469.121% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -10668.388% |
| Piramal Enterprises Limited | 60.33 Billion INR | -362.672% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | -163.227% |
| NATCO Pharma Limited | 40.02 Billion INR | -597.561% |
| Suven Life Sciences Limited | 116.92 Million INR | -238646.59% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -55266.064% |
| Strides Pharma Science Limited | 40.51 Billion INR | -589.103% |
| Indoco Remedies Limited | 18.17 Billion INR | -1436.155% |
| Alpa Laboratories Limited | 1.08 Billion INR | -25572.85% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -26656.506% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -36853.192% |